Your browser doesn't support javascript.
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
Innes, Andrew J; Cook, Lucy B; Marks, Sasha; Bataillard, Edward; Crossette-Thambiah, Christina; Sivasubramaniam, Gayathiri; Apperley, Jane; Milojkovic, Dragana.
  • Innes AJ; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.
  • Cook LB; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Marks S; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.
  • Bataillard E; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Crossette-Thambiah C; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Sivasubramaniam G; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Apperley J; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Milojkovic D; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
Br J Haematol ; 190(4): e198-e200, 2020 08.
Article in English | MEDLINE | ID: covidwho-614921
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pyrazoles / Hematopoietic Stem Cell Transplantation / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Adult / Humans / Male Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16979

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pyrazoles / Hematopoietic Stem Cell Transplantation / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Adult / Humans / Male Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16979